课题基金 / 基金详情

TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO

TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO
人乳腺上皮细胞的体外转化
批准号:
3193406
负责人:
Satyabrata Nandi
金额:
$20.85万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1994-05-31

项目摘要

项目成果

Satyabrata Nandi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our long term objective is to induce preneoplastic and neoplastic transformation of human mammary epithelial cells, under defined in vitro conditions, with direct- and indirect-acting chemical carcinogens. An ability to consistently transform human mammary cells under defined in vitro conditions is essential to designing experiments to understand the cellular-molecular events underlying transformation and histogenesis of human breast cancer(s). Our strategy is to transform human epithelial cells grown under serum- free conditions in a collagen gel culture system, as well as in monolayer culture systems using various matrices. Specifically, we will: a) analyze the growth regulation of normal, benign (fibrocystic) and carcinomatous human mammary cells in collagen culture, under serum-free conditions in the presence of hormones (estrogen, progesterone, prolactin, etc.), growth factors (EGF, FGF, TGF alpha, TGF beta, etc.) and nonhormonal agents (lipids, TPA, Li+); b) use these endpoints to design culture conditions which facilitate human mammary epithelial cell transformation at high yield, in a manner similar to those developed for transformation of murine epithelial cells; c) use cDNA probes to determine whether amplification, rearrangement or expression of plasminogen activators (tPA, urokinase), TGF alpha, TGF beta, EGF receptor, glutathione-s-transferase-P, gamma-glutamyl transpeptidase and 0-6 alkyl-DNA-alkyltransferase are reliable, quantitative molecular markers for transformation and tumor histogenesis; d) determine whether changes at the molecular level correlate with phenotype changes (karyotypic, immunocytochemical, ultramicroscopic); e) develop suitable in vitro and in vivo assay systems to identify those molecular-cellular changes which represent preneoplastic and neoplastic (malignant) transformants. Our experience and approach suggest that development of a system(s) for transformation of human mammary epithelial cell in vitro is an achievable goal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
  • 批准号:
    6173700
  • 项目类别:
  • 资助金额:
    $21.83万
  • 财政年份:
    1999
  • 负责人:
    Satyabrata Nandi
  • 依托单位:
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
  • 批准号:
    6513247
  • 项目类别:
  • 资助金额:
    $23.16万
  • 财政年份:
    1999
  • 负责人:
    Satyabrata Nandi
  • 依托单位:
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
  • 批准号:
    6376792
  • 项目类别:
  • 资助金额:
    $22.49万
  • 财政年份:
    1999
  • 负责人:
    Satyabrata Nandi
  • 依托单位:
国内基金
海外基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现